Nureca Ltd.

Nureca Ltd.

316.70
INR
-16.65
(-4.99%)
1.58EPS
150.47P/E
2.27BMarket Cap
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
28.12
86.81
139.44
285.54
255.54
111.32
91.93
109.66
149
155.05
Basic EPS, GAAP
4.36
8.73
8.97
62.04
44.96
-8.25
-1.79
0.85
2.11
1.58
Free Cash Flow per Basic Share
0.11
0.26
-11.69
45.67
-4.6
9.83
-3.8
-23.41
-3.58
- -
Dividend per Share
- -
- -
- -
- -
4.99
- -
- -
- -
- -
- -
Book Value per Share
1.72
8.54
14.93
163.1
203.2
194.88
193.11
194.28
189.44
- -
Tangible Book Value per Share
1.72
8.54
14.93
162.79
200.38
192.26
190.81
192.3
187.65
- -
Basic Weighted Avg Shares
7
7
7
7
10
10
10
10
10
10
Sales/Revenue/Turnover
201
619
994
2,135
2,555
1,113
919
1,097
1,470
1,496
Operating Margin (%)
21.79
14.54
9.37
29.15
21.45
-15.4
-13.67
-8.96
4.66
4.45
Depreciation Expense
- -
1
4
4
15
24
24
23
20
21
Net Income, GAAP
31
62
64
464
450
-82
-18
8
21
15
Effective Tax Rate (%)
28.01
29.58
25.71
25.6
26.27
- -
- -
37.01
58.22
68.38
Profit Margin (%)
15.52
10.06
6.43
21.73
17.59
-7.41
-1.95
0.77
1.42
1.02
Working Capital
17
83
232
1,623
1,940
1,777
1,833
1,776
1,009
- -
LT Debt
- -
3
93
33
33
20
18
26
8
- -
Total Equity
17
85
149
1,631
2,032
1,949
1,931
1,943
1,808
- -
Return on Invested Capital (%)
- -
118.37
38.47
45.84
20.91
- -
- -
-3.13
1.42
- -
Return on Capital (%)
- -
117.9
39.83
49.53
24.18
- -
- -
0.55
1.2
- -
Return on Common Equity (%)
- -
121.31
54.47
52.1
24.55
-4.14
-0.92
0.44
1.11
- -

Capital Structure

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
ST Debt
- -
14
- -
LT Borrowings
- -
2
- -
LT Finance Leases
- -
6
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
10
10
10
Market Capitalization
3,080
1,973
2,265

Working Capital

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
Total Current Assets
- -
1,147
- -
Cash, Cash Equivalents & STI
- -
130
- -
Accounts Receivable, Net
- -
77
- -
Inventories
- -
475
- -
Total Current Liabilities
- -
138
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
14
- -
Deferred Revenue
- -
- -
- -

Growth Rates

INR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
2.65%
-6.96%
Free Cash Flow
- -
-26.89%
-84.91%
Net Income, GAAP
- -
-40.14%
146.1%
Sales/Revenue/Turnover
- -
-0.17%
34.02%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
203
312
265
317
1,097
2026
342
- -
396
354
1,470
2027
403
- -
- -
- -
- -

Quarterly Earnings Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
1.66
-0.48
-2.8
2.47
0.85
2026
0.81
- -
3.91
-6.45
2.11
2027
3.21
- -
- -
- -
- -

Quarterly Dividends Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
2027
- -
- -
- -
- -
- -

Company Description

CEO
Saurabh Goyal
Full Time Employees
154
Sector
Health technology
Industry
Medical specialties
Address
SCO 6-7-8 Chandigarh PU India 160009
IPO Date
Feb 25, 2021
Website
nureca.com
Business
Nureca Limited operates as a consumer-focused enterprise, specializing in home healthcare and wellness devices within the Indian market. The company provides a comprehensive portfolio of products designed for various health needs, including managing chronic conditions, orthopedic support, and lifestyle enhancement. Its offerings encompass medical instruments such as nebulizers, blood pressure monitors, pulse oximeters, and glucose meters. Additionally, Nureca supplies orthopedic massagers and pain management tools, along with personal fitness items like smart scales and activity trackers, as well as dental and personal hygiene products. For new families, the company offers mother and baby care essentials, including feeding equipment and bottle warmers. These diverse products are marketed under its established brands: Dr Trust, primarily for health and wellness monitoring; Dr Physio, focusing on orthocare and pain relief; and Trumom, dedicated to mother and childcare solutions. Nureca distributes its range through major e-commerce platforms, its own website, drtrust.in, and various retail outlets, employing a digitally-driven, omnichannel strategy. Recognized for innovation in the healthcare sector, the company holds numerous patents and provides smart, connected devices, including its Dr Trust 360 IoT healthcare application. Its products are certified by organizations such as USFDA, CE, and ISO 13485. Nureca Limited was founded in 2016 and is headquartered in Chandigarh, India.